The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bio-Implants Market Research Report 2024
Synopsis
Bio-implants can be defined as prostheses used to regularize physiological functions. They are made up of biosynthetic materials like collagen, and tissue-engineered products like artificial skin or tissues. Most bioengineered products like cardiac pacemakers and orthopedic artificial implants are also covered under bio-implants, since they are implanted entirely in the patient’s body.
The global Bio-Implants market was valued at US$ 57480 million in 2023 and is anticipated to reach US$ 79980 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
North American market for Bio-Implants is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bio-Implants is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bio-Implants include AAP Implantate, Abbott Laboratories, Bausch and Lomb Incorporated, Biomet, Biotronik Se & Co.Kg, Boston Scientific Corporation, Cook Group, C.R. Bard and Edwards Lifesciences Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bio-Implants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-Implants.
Report Scope
The Bio-Implants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bio-Implants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio-Implants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AAP Implantate
Abbott Laboratories
Bausch and Lomb Incorporated
Biomet
Biotronik Se & Co.Kg
Boston Scientific Corporation
Cook Group
C.R. Bard
Edwards Lifesciences Corporation
Endo Health Solutions
Johnson & Johnson
Integra Lifesciences Holdings Corporation
Integrated Orbital Implants
Lifenet Health
Medtro
Mimedx Group
Orthofix International
Smith & Nephew
Sorin
Abbott
Segment by Type
Allograft
Autograft
Xenograft
Segment by Application
Cardiovascular Implants
Spinal Implants
Orthopedics & Trauma
Dental
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bio-Implants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bio-Implants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Bio-implants can be defined as prostheses used to regularize physiological functions. They are made up of biosynthetic materials like collagen, and tissue-engineered products like artificial skin or tissues. Most bioengineered products like cardiac pacemakers and orthopedic artificial implants are also covered under bio-implants, since they are implanted entirely in the patient’s body.
The global Bio-Implants market was valued at US$ 57480 million in 2023 and is anticipated to reach US$ 79980 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
North American market for Bio-Implants is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bio-Implants is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bio-Implants include AAP Implantate, Abbott Laboratories, Bausch and Lomb Incorporated, Biomet, Biotronik Se & Co.Kg, Boston Scientific Corporation, Cook Group, C.R. Bard and Edwards Lifesciences Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bio-Implants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-Implants.
Report Scope
The Bio-Implants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bio-Implants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio-Implants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AAP Implantate
Abbott Laboratories
Bausch and Lomb Incorporated
Biomet
Biotronik Se & Co.Kg
Boston Scientific Corporation
Cook Group
C.R. Bard
Edwards Lifesciences Corporation
Endo Health Solutions
Johnson & Johnson
Integra Lifesciences Holdings Corporation
Integrated Orbital Implants
Lifenet Health
Medtro
Mimedx Group
Orthofix International
Smith & Nephew
Sorin
Abbott
Segment by Type
Allograft
Autograft
Xenograft
Segment by Application
Cardiovascular Implants
Spinal Implants
Orthopedics & Trauma
Dental
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bio-Implants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bio-Implants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Bio-Implants Market Overview
1.1 Product Overview and Scope of Bio-Implants
1.2 Bio-Implants Segment by Type
1.2.1 Global Bio-Implants Market Value Comparison by Type (2024-2030)
1.2.2 Allograft
1.2.3 Autograft
1.2.4 Xenograft
1.3 Bio-Implants Segment by Application
1.3.1 Global Bio-Implants Market Value by Application: (2024-2030)
1.3.2 Cardiovascular Implants
1.3.3 Spinal Implants
1.3.4 Orthopedics & Trauma
1.3.5 Dental
1.3.6 Others
1.4 Global Bio-Implants Market Size Estimates and Forecasts
1.4.1 Global Bio-Implants Revenue 2019-2030
1.4.2 Global Bio-Implants Sales 2019-2030
1.4.3 Global Bio-Implants Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bio-Implants Market Competition by Manufacturers
2.1 Global Bio-Implants Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bio-Implants Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bio-Implants Average Price by Manufacturers (2019-2024)
2.4 Global Bio-Implants Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bio-Implants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bio-Implants, Product Type & Application
2.7 Bio-Implants Market Competitive Situation and Trends
2.7.1 Bio-Implants Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bio-Implants Players Market Share by Revenue
2.7.3 Global Bio-Implants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bio-Implants Retrospective Market Scenario by Region
3.1 Global Bio-Implants Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bio-Implants Global Bio-Implants Sales by Region: 2019-2030
3.2.1 Global Bio-Implants Sales by Region: 2019-2024
3.2.2 Global Bio-Implants Sales by Region: 2025-2030
3.3 Global Bio-Implants Global Bio-Implants Revenue by Region: 2019-2030
3.3.1 Global Bio-Implants Revenue by Region: 2019-2024
3.3.2 Global Bio-Implants Revenue by Region: 2025-2030
3.4 North America Bio-Implants Market Facts & Figures by Country
3.4.1 North America Bio-Implants Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bio-Implants Sales by Country (2019-2030)
3.4.3 North America Bio-Implants Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bio-Implants Market Facts & Figures by Country
3.5.1 Europe Bio-Implants Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bio-Implants Sales by Country (2019-2030)
3.5.3 Europe Bio-Implants Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bio-Implants Market Facts & Figures by Country
3.6.1 Asia Pacific Bio-Implants Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bio-Implants Sales by Country (2019-2030)
3.6.3 Asia Pacific Bio-Implants Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bio-Implants Market Facts & Figures by Country
3.7.1 Latin America Bio-Implants Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bio-Implants Sales by Country (2019-2030)
3.7.3 Latin America Bio-Implants Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bio-Implants Market Facts & Figures by Country
3.8.1 Middle East and Africa Bio-Implants Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bio-Implants Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bio-Implants Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Bio-Implants Sales by Type (2019-2030)
4.1.1 Global Bio-Implants Sales by Type (2019-2024)
4.1.2 Global Bio-Implants Sales by Type (2025-2030)
4.1.3 Global Bio-Implants Sales Market Share by Type (2019-2030)
4.2 Global Bio-Implants Revenue by Type (2019-2030)
4.2.1 Global Bio-Implants Revenue by Type (2019-2024)
4.2.2 Global Bio-Implants Revenue by Type (2025-2030)
4.2.3 Global Bio-Implants Revenue Market Share by Type (2019-2030)
4.3 Global Bio-Implants Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bio-Implants Sales by Application (2019-2030)
5.1.1 Global Bio-Implants Sales by Application (2019-2024)
5.1.2 Global Bio-Implants Sales by Application (2025-2030)
5.1.3 Global Bio-Implants Sales Market Share by Application (2019-2030)
5.2 Global Bio-Implants Revenue by Application (2019-2030)
5.2.1 Global Bio-Implants Revenue by Application (2019-2024)
5.2.2 Global Bio-Implants Revenue by Application (2025-2030)
5.2.3 Global Bio-Implants Revenue Market Share by Application (2019-2030)
5.3 Global Bio-Implants Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AAP Implantate
6.1.1 AAP Implantate Corporation Information
6.1.2 AAP Implantate Description and Business Overview
6.1.3 AAP Implantate Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AAP Implantate Bio-Implants Product Portfolio
6.1.5 AAP Implantate Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Laboratories Bio-Implants Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Bausch and Lomb Incorporated
6.3.1 Bausch and Lomb Incorporated Corporation Information
6.3.2 Bausch and Lomb Incorporated Description and Business Overview
6.3.3 Bausch and Lomb Incorporated Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bausch and Lomb Incorporated Bio-Implants Product Portfolio
6.3.5 Bausch and Lomb Incorporated Recent Developments/Updates
6.4 Biomet
6.4.1 Biomet Corporation Information
6.4.2 Biomet Description and Business Overview
6.4.3 Biomet Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biomet Bio-Implants Product Portfolio
6.4.5 Biomet Recent Developments/Updates
6.5 Biotronik Se & Co.Kg
6.5.1 Biotronik Se & Co.Kg Corporation Information
6.5.2 Biotronik Se & Co.Kg Description and Business Overview
6.5.3 Biotronik Se & Co.Kg Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biotronik Se & Co.Kg Bio-Implants Product Portfolio
6.5.5 Biotronik Se & Co.Kg Recent Developments/Updates
6.6 Boston Scientific Corporation
6.6.1 Boston Scientific Corporation Corporation Information
6.6.2 Boston Scientific Corporation Description and Business Overview
6.6.3 Boston Scientific Corporation Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boston Scientific Corporation Bio-Implants Product Portfolio
6.6.5 Boston Scientific Corporation Recent Developments/Updates
6.7 Cook Group
6.6.1 Cook Group Corporation Information
6.6.2 Cook Group Description and Business Overview
6.6.3 Cook Group Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cook Group Bio-Implants Product Portfolio
6.7.5 Cook Group Recent Developments/Updates
6.8 C.R. Bard
6.8.1 C.R. Bard Corporation Information
6.8.2 C.R. Bard Description and Business Overview
6.8.3 C.R. Bard Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.8.4 C.R. Bard Bio-Implants Product Portfolio
6.8.5 C.R. Bard Recent Developments/Updates
6.9 Edwards Lifesciences Corporation
6.9.1 Edwards Lifesciences Corporation Corporation Information
6.9.2 Edwards Lifesciences Corporation Description and Business Overview
6.9.3 Edwards Lifesciences Corporation Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Edwards Lifesciences Corporation Bio-Implants Product Portfolio
6.9.5 Edwards Lifesciences Corporation Recent Developments/Updates
6.10 Endo Health Solutions
6.10.1 Endo Health Solutions Corporation Information
6.10.2 Endo Health Solutions Description and Business Overview
6.10.3 Endo Health Solutions Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Endo Health Solutions Bio-Implants Product Portfolio
6.10.5 Endo Health Solutions Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Corporation Information
6.11.2 Johnson & Johnson Bio-Implants Description and Business Overview
6.11.3 Johnson & Johnson Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Johnson & Johnson Bio-Implants Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 Integra Lifesciences Holdings Corporation
6.12.1 Integra Lifesciences Holdings Corporation Corporation Information
6.12.2 Integra Lifesciences Holdings Corporation Bio-Implants Description and Business Overview
6.12.3 Integra Lifesciences Holdings Corporation Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Integra Lifesciences Holdings Corporation Bio-Implants Product Portfolio
6.12.5 Integra Lifesciences Holdings Corporation Recent Developments/Updates
6.13 Integrated Orbital Implants
6.13.1 Integrated Orbital Implants Corporation Information
6.13.2 Integrated Orbital Implants Bio-Implants Description and Business Overview
6.13.3 Integrated Orbital Implants Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Integrated Orbital Implants Bio-Implants Product Portfolio
6.13.5 Integrated Orbital Implants Recent Developments/Updates
6.14 Lifenet Health
6.14.1 Lifenet Health Corporation Information
6.14.2 Lifenet Health Bio-Implants Description and Business Overview
6.14.3 Lifenet Health Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lifenet Health Bio-Implants Product Portfolio
6.14.5 Lifenet Health Recent Developments/Updates
6.15 Medtro
6.15.1 Medtro Corporation Information
6.15.2 Medtro Bio-Implants Description and Business Overview
6.15.3 Medtro Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Medtro Bio-Implants Product Portfolio
6.15.5 Medtro Recent Developments/Updates
6.16 Mimedx Group
6.16.1 Mimedx Group Corporation Information
6.16.2 Mimedx Group Bio-Implants Description and Business Overview
6.16.3 Mimedx Group Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Mimedx Group Bio-Implants Product Portfolio
6.16.5 Mimedx Group Recent Developments/Updates
6.17 Orthofix International
6.17.1 Orthofix International Corporation Information
6.17.2 Orthofix International Bio-Implants Description and Business Overview
6.17.3 Orthofix International Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Orthofix International Bio-Implants Product Portfolio
6.17.5 Orthofix International Recent Developments/Updates
6.18 Smith & Nephew
6.18.1 Smith & Nephew Corporation Information
6.18.2 Smith & Nephew Bio-Implants Description and Business Overview
6.18.3 Smith & Nephew Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Smith & Nephew Bio-Implants Product Portfolio
6.18.5 Smith & Nephew Recent Developments/Updates
6.19 Sorin
6.19.1 Sorin Corporation Information
6.19.2 Sorin Bio-Implants Description and Business Overview
6.19.3 Sorin Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Sorin Bio-Implants Product Portfolio
6.19.5 Sorin Recent Developments/Updates
6.20 Abbott
6.20.1 Abbott Corporation Information
6.20.2 Abbott Bio-Implants Description and Business Overview
6.20.3 Abbott Bio-Implants Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Abbott Bio-Implants Product Portfolio
6.20.5 Abbott Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bio-Implants Industry Chain Analysis
7.2 Bio-Implants Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bio-Implants Production Mode & Process
7.4 Bio-Implants Sales and Marketing
7.4.1 Bio-Implants Sales Channels
7.4.2 Bio-Implants Distributors
7.5 Bio-Implants Customers
8 Bio-Implants Market Dynamics
8.1 Bio-Implants Industry Trends
8.2 Bio-Implants Market Drivers
8.3 Bio-Implants Market Challenges
8.4 Bio-Implants Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
